Analysts have been eager to weigh in on the Healthcare sector with new ratings on Horizon Pharma Inc (NASDAQ:HZNP) and La Jolla Pharma (NASDAQ:LJPC).
Horizon Pharma Inc (HZNP)
Jefferies analyst David Steinberg reiterated a Buy rating on Horizon Pharma Inc today and set a price target of $23. The company’s shares closed yesterday at $20.12, close to its 52-week high of $20.25.
According to TipRanks.com, Steinberg is a 4-star analyst with an average return of 10.6% and a 50.6% success rate. Steinberg covers the Healthcare sector, focusing on stocks such as Bausch Health Companies Inc, Supernus Pharmaceuticals, and Collegium Pharmaceutical.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Horizon Pharma Inc with a $21.83 average price target, representing an 8.5% upside. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $21 price target.
.
See today’s analyst top recommended stocks >>
La Jolla Pharma (LJPC)
Jefferies analyst Eun Yang reiterated a Sell rating on La Jolla Pharma yesterday and set a price target of $22. The company’s shares closed yesterday at $32.79.
According to TipRanks.com, Yang is a 4-star analyst with an average return of 5.1% and a 51.0% success rate. Yang covers the Healthcare sector, focusing on stocks such as Dova Pharmaceuticals Inc, Alexion Pharmaceuticals, and Amag Pharmaceuticals.
La Jolla Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $59.40.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
